Buscar resultados de ensayos clínicos

Patrocinado por

Abdominal Neoplasms - 350 Studies Found

Estado Estudiar
Completed Nombre del estudio: BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer
Condición:
  • Ovarian Neoplasms
  • Peritoneal Neoplasms

Fecha: 2011-03-08
Intervenciones:
  • Drug: BIBF 1120 + PLD 30 mg/m2 + CBDCA AUC5 mg/mL*min

Completed Nombre del estudio: Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Condición:
  • Ovarian Neoplasms
  • Fallopian Tube Neoplasms
  • Primary Periton
    Fecha: 2011-03-09
    Intervenciones: Drug: Pegylated L-Asparaginase Pegaspargase 2000 IU/m^2 intramuscular or intravenously every 2 weeks
Active, not recruiting Nombre del estudio: A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Condición:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Ca
    Fecha: 2011-03-01
    Intervenciones:
    • Biological: OC-L/Montanide ISA 51 VG

Active, not recruiting Nombre del estudio: Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
Condición:
  • Ovarian Carcinoma
  • Fallopian Tube Cancer
  • Primary Peritoneal
    Fecha: 2011-03-09
    Intervenciones:
    • Biological: OC-DC vaccine All

Completed Nombre del estudio: Carboplatin, Pegylated Liposomal Doxorubicin Hydrochloride, and Everolimus in Treating Patients With Relapsed Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Condición:
  • Fallopian Tube Cancer
  • Peritoneal Cavity Cancer
  • Recurrent O
    Fecha: 2011-01-12
    Intervenciones:
    • Drug: everolimus Given PO
Terminated Nombre del estudio: Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Condición:
  • Neoplasms
  • Ovarian Neoplasms
  • Fallopian Tube Neoplasms

    • Fecha: 2011-01-11
    Intervenciones:
    • Biological: KHK2866 Potentiall
Suspended Nombre del estudio: Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Condición:
  • Nausea and Vomiting
  • Ovarian Brenner Tumor
  • Ovarian Clear Ce
    Fecha: 2011-01-11
    Intervenciones:
    • Procedure: Adjuvant Therapy An
Active, not recruiting Nombre del estudio: Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer
Condición:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer Fecha: 2010-11-24
    Intervenciones:
    • Drug: carboplatin Carboplatin

Active, not recruiting Nombre del estudio: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab
Condición:
  • Fallopian Tubes Cancer
  • Ovarian Cancer
  • Peritoneal Cancer Fecha: 2010-10-14
    Intervenciones: Biological: bevacizumab and the polyvalent vaccine-KLH conjugate + OPT-821 A maximum of 6 doses of the p
Completed Nombre del estudio: Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel Bevacizumab for Primary Ovarian
Condición:
  • Ovarian Cancer
  • Primary Peritoneal Cancer
  • Fallopian Tube Ca
    Fecha: 2010-10-11
    Intervenciones:
    • Drug: carboplatin Carboplatin

<<< Previous | Next >>>